289 related articles for article (PubMed ID: 18095948)
21. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
[TBL] [Abstract][Full Text] [Related]
22. Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs.
Zhou J; Zheng F; Guo X; Yang H; Zhang M; Tian H; Guo L; Li Q; Mo Y; Jia W
Diabetes Metab Res Rev; 2015 Oct; 31(7):725-33. PubMed ID: 25952634
[TBL] [Abstract][Full Text] [Related]
23. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
Yki-Järvinen H; Dressler A; Ziemen M;
Diabetes Care; 2000 Aug; 23(8):1130-6. PubMed ID: 10937510
[TBL] [Abstract][Full Text] [Related]
24. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.
Bretzel RG; Nuber U; Landgraf W; Owens DR; Bradley C; Linn T
Lancet; 2008 Mar; 371(9618):1073-84. PubMed ID: 18374840
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
26. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
Raskin P; Allen E; Hollander P; Lewin A; Gabbay RA; Hu P; Bode B; Garber A;
Diabetes Care; 2005 Feb; 28(2):260-5. PubMed ID: 15677776
[TBL] [Abstract][Full Text] [Related]
27. A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes.
Fogelfeld L; Dharmalingam M; Robling K; Jones C; Swanson D; Jacober S
Diabet Med; 2010 Feb; 27(2):181-8. PubMed ID: 20546262
[TBL] [Abstract][Full Text] [Related]
28. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
29. Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.
Bergenstal RM; Johnson M; Powers MA; Wynne A; Vlajnic A; Hollander P; Rendell M
Diabetes Care; 2008 Jul; 31(7):1305-10. PubMed ID: 18364392
[TBL] [Abstract][Full Text] [Related]
30. Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections.
Riddle MC; Rosenstock J; Vlajnic A; Gao L
Diabetes Obes Metab; 2014 May; 16(5):396-402. PubMed ID: 24118931
[TBL] [Abstract][Full Text] [Related]
31. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.
Yki-Järvinen H; Kauppinen-Mäkelin R; Tiikkainen M; Vähätalo M; Virtamo H; Nikkilä K; Tulokas T; Hulme S; Hardy K; McNulty S; Hänninen J; Levänen H; Lahdenperä S; Lehtonen R; Ryysy L
Diabetologia; 2006 Mar; 49(3):442-51. PubMed ID: 16456680
[TBL] [Abstract][Full Text] [Related]
32. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
[TBL] [Abstract][Full Text] [Related]
33. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study.
Polonsky WH; Fisher L; Schikman CH; Hinnen DA; Parkin CG; Jelsovsky Z; Petersen B; Schweitzer M; Wagner RS
Diabetes Care; 2011 Feb; 34(2):262-7. PubMed ID: 21270183
[TBL] [Abstract][Full Text] [Related]
34. Self-titration of biphasic insulin aspart 30/70 improves glycaemic control and allows easy intensification in a Dutch clinical practice.
Ligthelm RJ
Prim Care Diabetes; 2009 May; 3(2):97-102. PubMed ID: 19285933
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.
Li CJ; Li J; Zhang QM; Lv L; Chen R; Lv CF; Yu P; Yu DM
Cardiovasc Diabetol; 2012 Nov; 11():142. PubMed ID: 23153177
[TBL] [Abstract][Full Text] [Related]
36. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.
Davies M; Lavalle-González F; Storms F; Gomis R;
Diabetes Obes Metab; 2008 May; 10(5):387-99. PubMed ID: 18355327
[TBL] [Abstract][Full Text] [Related]
37. Insulin during pregnancy, labour and delivery.
de Valk HW; Visser GH
Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
[TBL] [Abstract][Full Text] [Related]
38. Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy.
Berhanu P; Perez A; Yu S
Diabetes Obes Metab; 2007 Jul; 9(4):512-20. PubMed ID: 17587394
[TBL] [Abstract][Full Text] [Related]
39. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
Riddle MC; Rosenstock J; Gerich J;
Diabetes Care; 2003 Nov; 26(11):3080-6. PubMed ID: 14578243
[TBL] [Abstract][Full Text] [Related]
40. Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.
Ziegler R; Eichholz R; Schulz B
J Diabetes Sci Technol; 2015 May; 9(6):1270-4. PubMed ID: 25986628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
